The management board and supervisory board of BioNTech SE have proposed a special cash dividend of 2.00 per ordinary share (including those held in the form of ADSs), which corresponds to an aggregate of approximately 486.0 million, based on the number of ordinary shares and ADSs outstanding as of April 30, 2022, pending approval at the Annual General Meeting to be held in June 2022, which the company expects to serve as the record date for the dividend.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
86.34 USD | -1.76% | -4.12% | -18.19% |
Apr. 15 | Global markets live: Goldman Sachs, Apple, Salesforce, Boeing Tesla... | |
Apr. 15 | Market outlook is uncertain, but optimism prevails |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.19% | 20.81B | |
-3.13% | 102B | |
+1.80% | 96.09B | |
+0.35% | 22.05B | |
-5.99% | 19.06B | |
-43.39% | 16.05B | |
-25.68% | 14.01B | |
+0.93% | 13.38B | |
+21.63% | 11.01B | |
-16.70% | 9.12B |
- Stock Market
- Equities
- BNTX Stock
- News BioNTech SE
- BioNTech SE Proposes Special Cash Dividend